The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
Related Posts
Racing to Retake a Beloved Trip, Before Dementia Takes Everything
When I was growing up, my dad, who has left the country only a few times, told me about the…
Vaccines Significantly Reduce the Risk of Long Covid, Study Finds
In the first two years of the pandemic, the rate of long Covid was starkly lower among people who were…
How Science Went to the Dogs (and Cats)
These early studies “highlighted both the potential that we could learn from dogs, but also that we were going to…